Article info
Original Articles
Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer
- Address for correspondence: M.C. Palmer, Department of Medicine, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2.
Citation
Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer
Publication history
- First published November 1, 1992.
Online issue publication
February 26, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
International Gynecologic Cancer Society